A phase 1, single- and repeated-dose, randomized, open-label, multi-center study to evaluate the pharmacokinetics, pharmacodynamics and safety of lansoprazole in neonates with clinically-evident gastroesophageal reflux disease.
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Lansoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 05 Nov 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History